Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24,216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of Daratumumab in Intermediate/High-risk Smoldering Multiple Myeloma: Final Analysis of CENTAURUS.
Landgren CO, Chari A, Cohen YC, Spencer A, Voorhees PM, Sandhu I, Jenner MW, Smith D, Cavo M, van de Donk NWCJ, Beksac M, Moreau P, Goldschmidt H, Vieyra D, Sha L, Li L, Rousseau E, Dennis RM, Carson R, Hofmeister CC. Landgren CO, et al. Among authors: smith d. Blood. 2024 Dec 9:blood.2024025897. doi: 10.1182/blood.2024025897. Online ahead of print. Blood. 2024. PMID: 39652826
Prevalence and timing of TP53 mutations in del(17p) myeloma and effect on survival.
Chin M, Sive JI, Allen C, Roddie C, Chavda SJ, Smith D, Blombery P, Jones K, Ryland GL, Popat R, Rismani A, D'Sa S, Rabin N, Gale RE, Yong KL. Chin M, et al. Among authors: d sa s, smith d. Blood Cancer J. 2017 Sep 15;7(9):e610. doi: 10.1038/bcj.2017.76. Blood Cancer J. 2017. PMID: 29016571 Free PMC article. Clinical Trial. No abstract available.
Drop metastases in multiple myeloma.
Fisken R, Abuhassan A, Smith D. Fisken R, et al. Among authors: smith d. Br J Haematol. 2021 May;193(3):444. doi: 10.1111/bjh.17305. Epub 2021 Feb 19. Br J Haematol. 2021. PMID: 33605436 No abstract available.
Advances in understanding prognosis in myeloma.
Smith D, Yong K. Smith D, et al. Br J Haematol. 2016 Nov;175(3):367-380. doi: 10.1111/bjh.14304. Epub 2016 Sep 8. Br J Haematol. 2016. PMID: 27604166 Free article. Review.
Multiple myeloma.
Smith D, Yong K. Smith D, et al. BMJ. 2013 Jun 26;346:f3863. doi: 10.1136/bmj.f3863. BMJ. 2013. PMID: 23803862 Review. No abstract available.
RAS mutation status and bortezomib therapy for relapsed multiple myeloma.
Smith D, Armenteros E, Percy L, Kumar M, Lach A, Herledan G, Stubbs M, Downward J, Yong K. Smith D, et al. Br J Haematol. 2015 Jun;169(6):905-8. doi: 10.1111/bjh.13258. Epub 2015 Jan 12. Br J Haematol. 2015. PMID: 25580780 Free article. No abstract available.
24,216 results
You have reached the last available page of results. Please see the User Guide for more information.